All laws›Par CentralPharma Communications SIA (Reģ. Nr.40003521795) medikamenta Epclusa (Sofosbuvirum/ Velpatasvirum) apvalkotas tabletes 400/100mg Nr.28 iekļaušanu Kompensējamo zāļu sarakstā

1. Article

Iekļaut medikamentu Epclusa (Sofosbuvirum/ Velpatasvirum) apvalkotas tabletes 400/100mg Nr.28 (ID EU/1/16/1116/001) Kompensējamo zāļu C sarakstā.

asjoint-stockpharmaceuticals

Verify on the source (likumi.lv) ↗

Reference only — not legal advice. The corpus mirrors statutory text (including repealed editions); a result may be superseded. Always verify against the current consolidated version on likumi.lv before relying on it.